FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4212821061> ?p ?o ?g. }

• W4212821061 abstract "There is an increasing incidence of destructive bone disease caused by osteoclast proliferation. This is characterized by reduced bone mass and imbalance of bone homeostasis. Icariin (ICA), a flavonoid compound isolated from Epimedium, has anti‑osteoporosis activity and inhibits the formation of osteoclasts and bone resorption. The purpose of the present study was to investigate the protective effect of ICA on osteoclastic differentiation induced by thioacetamide (TAA) and its possible mechanism in Sprague Dawley (SD) rats. In the present study, SD rats were intraperitoneally injected with TAA (300 mg/kg) for the bone loss model, treated with ICA (600 mg/kg, intragastric gavage) in the ICA group and TAA+ICA group for treatment of bone loss for 6 weeks. Indexes associated with bone metabolism, such as alkaline phosphatase, N‑terminal telopeptide of type‑I collagen (NTX‑I), calcium (Ca), phosphorus (P) and magnesium (Mg) in the serum, were detected. Osteoclast differentiation of femoral tissues was detected by hematoxylin and eosin and tartrate‑resistant acid phosphatase staining. The femoral bone mass was evaluated using a three‑point bending test and micro computed tomography. Western blotting was used to detect the expression levels of osteoclast‑related proteins in each group. In the rats treated with TAA, the serum concentrations of Ca, P and Mg were decreased, the serum concentration of NTX‑I was increased, osteoclast differentiation of the femur was increased, femur bone stress and bone mass were decreased and the bone loss and osteoclast formation were reduced after ICA treatment. In addition, ICA inhibited the protein expression of receptor activator of nuclear factor κ‑Β ligand (RANKL), receptor activator of nuclear factor κ‑B (RANK), p38, ERK, c‑Fos and nuclear factor of activated T cells 1 (NFATc1) in the femur of rats treated with TAA. The results suggested that ICA may inhibit osteoclast differentiation by downregulating the RANKL‑p38/ERK‑NFAT signaling pathway and prevent TAA‑induced bone loss. The results are helpful to understand the mechanism of osteoclast differentiation induced by TAA, as well as the antiresorptive activity and molecular mechanism of ICA, and to provide new ideas for the treatment of osteolytic diseases." @default.
• W4212821061 created "2022-02-24" @default.
• W4212821061 creator A5035584184 @default.
• W4212821061 creator A5040326036 @default.
• W4212821061 creator A5052813004 @default.
• W4212821061 creator A5059353840 @default.
• W4212821061 creator A5087333350 @default.
• W4212821061 creator A5087695394 @default.
• W4212821061 creator A5087894090 @default.
• W4212821061 date "2022-02-14" @default.
• W4212821061 modified "2023-09-27" @default.
• W4212821061 title "Icariin attenuates thioacetamide‑induced bone loss via the RANKL‑p38/ERK‑NFAT signaling pathway" @default.
• W4212821061 cites W1855535452 @default.
• W4212821061 cites W1979344569 @default.
• W4212821061 cites W1982863111 @default.
• W4212821061 cites W2004448849 @default.
• W4212821061 cites W2016201042 @default.
• W4212821061 cites W2019189597 @default.
• W4212821061 cites W2026387061 @default.
• W4212821061 cites W2026684002 @default.
• W4212821061 cites W203392254 @default.
• W4212821061 cites W2042292944 @default.
• W4212821061 cites W2042998012 @default.
• W4212821061 cites W2055517213 @default.
• W4212821061 cites W2057649851 @default.
• W4212821061 cites W2074775112 @default.
• W4212821061 cites W2085394789 @default.
• W4212821061 cites W2091199400 @default.
• W4212821061 cites W2103424113 @default.
• W4212821061 cites W2107277218 @default.
• W4212821061 cites W2150309926 @default.
• W4212821061 cites W2192080449 @default.
• W4212821061 cites W2270760573 @default.
• W4212821061 cites W2335583289 @default.
• W4212821061 cites W2524213680 @default.
• W4212821061 cites W2587600317 @default.
• W4212821061 cites W2783949367 @default.
• W4212821061 cites W2799946064 @default.
• W4212821061 cites W2802469025 @default.
• W4212821061 cites W2805733706 @default.
• W4212821061 cites W2810284427 @default.
• W4212821061 cites W2883085792 @default.
• W4212821061 cites W2891400143 @default.
• W4212821061 cites W2892050758 @default.
• W4212821061 cites W2898670022 @default.
• W4212821061 cites W2900415432 @default.
• W4212821061 cites W2917535404 @default.
• W4212821061 cites W2925297832 @default.
• W4212821061 cites W2946313381 @default.
• W4212821061 cites W2998866213 @default.
• W4212821061 cites W3016559380 @default.
• W4212821061 cites W3016786862 @default.
• W4212821061 cites W3019236421 @default.
• W4212821061 cites W3024496687 @default.
• W4212821061 cites W3035139290 @default.
• W4212821061 cites W3041794428 @default.
• W4212821061 cites W3044783254 @default.
• W4212821061 cites W3049667941 @default.
• W4212821061 cites W3087664139 @default.
• W4212821061 cites W3092395887 @default.
• W4212821061 cites W3095765384 @default.
• W4212821061 cites W3096088109 @default.
• W4212821061 cites W3112125589 @default.
• W4212821061 cites W9111973 @default.
• W4212821061 doi "https://doi.org/10.3892/mmr.2022.12642" @default.
• W4212821061 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35169865" @default.
• W4212821061 hasPublicationYear "2022" @default.
• W4212821061 type Work @default.
• W4212821061 citedByCount "3" @default.
• W4212821061 countsByYear W42128210612023 @default.
• W4212821061 crossrefType "journal-article" @default.
• W4212821061 hasAuthorship W4212821061A5035584184 @default.
• W4212821061 hasAuthorship W4212821061A5040326036 @default.
• W4212821061 hasAuthorship W4212821061A5052813004 @default.
• W4212821061 hasAuthorship W4212821061A5059353840 @default.
• W4212821061 hasAuthorship W4212821061A5087333350 @default.
• W4212821061 hasAuthorship W4212821061A5087695394 @default.
• W4212821061 hasAuthorship W4212821061A5087894090 @default.
• W4212821061 hasBestOaLocation W42128210611 @default.
• W4212821061 hasConcept C126322002 @default.
• W4212821061 hasConcept C134018914 @default.
• W4212821061 hasConcept C142724271 @default.
• W4212821061 hasConcept C170033053 @default.
• W4212821061 hasConcept C170493617 @default.
• W4212821061 hasConcept C180675623 @default.
• W4212821061 hasConcept C185592680 @default.
• W4212821061 hasConcept C204787440 @default.
• W4212821061 hasConcept C2776033226 @default.
• W4212821061 hasConcept C2776541429 @default.
• W4212821061 hasConcept C2779428903 @default.
• W4212821061 hasConcept C2780685212 @default.
• W4212821061 hasConcept C673006 @default.
• W4212821061 hasConcept C71924100 @default.
• W4212821061 hasConcept C88045685 @default.
• W4212821061 hasConceptScore W4212821061C126322002 @default.
• W4212821061 hasConceptScore W4212821061C134018914 @default.
• W4212821061 hasConceptScore W4212821061C142724271 @default.
• W4212821061 hasConceptScore W4212821061C170033053 @default.
• W4212821061 hasConceptScore W4212821061C170493617 @default.
• W4212821061 hasConceptScore W4212821061C180675623 @default.

• next